This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, X.
Right arrow Articles by Van Dyke, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, X.
Right arrow Articles by Van Dyke, T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2001, p. 6017-6030, Vol. 21, No. 17
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.17.6017-6030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability

Xiangdong Lu,1 Gregg Magrane,2 Chaoying Yin,1 David N. Louis,3 Joe Gray,2 and Terry Van Dyke1,*

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 275991; Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California 941432; and Molecular Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 021293

Received 3 April 2001/Returned for modification 22 May 2001/Accepted 4 June 2001

We examined the selective pressure for, and the impact of, p53 inactivation during epithelial tumor evolution in a transgenic brain tumor model. In TgT121 mice, cell-specific inactivation of the pRb pathway in brain choroid plexus epithelium initiates tumorigenesis and induces p53-dependent apoptosis. We previously showed that p53 deficiency accelerates tumor growth due to diminished apoptosis. Here we show that in a p53+/- background, slow-growing dysplastic tissue undergoes clonal progression to solid angiogenic tumors in all animals. p53 is inactivated in all progressed tumors, with loss of the wild-type allele occurring in 90% of tumors. Moreover, similar progression occurs in 38% of TgT121p53+/+ mice, also with loss of at least one p53 allele and inactivation of p53. Thus, the selective pressure for p53 inactivation, likely based on its apoptotic function, is high. Yet, in all cases, p53 inactivation correlates with progression beyond apoptosis reduction, from dysplasia to solid vascularized tumors. Hence, p53 suppresses tumor progression in this tissue by multiple mechanisms. Previous studies of fibroblasts and hematopoietic cells show that p53 deficiency can be associated with chromosomal instability, a mechanism that may drive tumor progression. To determine whether genomic gains or losses are present in tumors that progress in the absence of p53, we performed comparative genomic hybridization analysis. Surprisingly, the only detectable chromosomal imbalance was partial or complete loss of chromosome 11, which harbors the p53 gene and is thus the selected event. Flow cytometry confirmed that the majority of tumor cells were diploid. These studies indicate that loss of p53 function is frequent under natural selective pressures and furthermore that p53 loss can facilitate epithelial tumor progression by a mechanism in addition to apoptosis reduction and distinct from chromosomal instability.

* Corresponding author. Mailing address: Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Phone: (919) 962-2145. Fax: (919) 962-4296. E-mail: tvdlab{at}med.unc.edu.

Molecular and Cellular Biology, September 2001, p. 6017-6030, Vol. 21, No. 17
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.17.6017-6030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Suehiro, Y., Okada, T., Okada, T., Anno, K., Okayama, N., Ueno, K., Hiura, M., Nakamura, M., Kondo, T., Oga, A., Kawauchi, S., Hirabayashi, K., Numa, F., Ito, T., Saito, T., Sasaki, K., Hinoda, Y. (2008). Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation. Clin. Cancer Res. 14: 3354-3361 [Abstract] [Full Text]  
  • Lu, X., Yang, C., Hill, R., Yin, C., Hollander, M. C., Fornace, A. J. Jr, Van Dyke, T. (2008). Inactivation of gadd45a Sensitizes Epithelial Cancer Cells to Ionizing Radiation In vivo Resulting in Prolonged Survival. Cancer Res. 68: 3579-3583 [Abstract] [Full Text]  
  • van de Wetering, C. I., Knudson, C. M. (2007). Chromosomal Instability and Supernumerary Centrosomes Represent Precursor Defects in a Mouse Model of T-Cell Lymphoma. Cancer Res. 67: 8081-8088 [Abstract] [Full Text]  
  • Chai, J., Lu, X., Godfrey, V., Fletcher, C., Roberts, C. W.M., Van Dyke, T., Weissman, B. E. (2007). Tumor-Specific Cooperation of Retinoblastoma Protein Family and Snf5 Inactivation. Cancer Res. 67: 3002-3009 [Abstract] [Full Text]  
  • Si, H., Robertson, E. S. (2006). Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function. J. Virol. 80: 697-709 [Abstract] [Full Text]  
  • Hill, R., Song, Y., Cardiff, R. D., Van Dyke, T. (2005). Heterogeneous Tumor Evolution Initiated by Loss of pRb Function in a Preclinical Prostate Cancer Model. Cancer Res. 65: 10243-10254 [Abstract] [Full Text]  
  • Xiao, A., Yin, C., Yang, C., Di Cristofano, A., Pandolfi, P. P., Van Dyke, T. (2005). Somatic Induction of Pten Loss in a Preclinical Astrocytoma Model Reveals Major Roles in Disease Progression and Avenues for Target Discovery and Validation. Cancer Res. 65: 5172-5180 [Abstract] [Full Text]  
  • SIMIN, K., HILL, R., SONG, Y., ZHANG, Q., BASH, R., CARDIFF, R.D., YIN, C., XIAO, A., McCARTHY, K., DYKE, T. V. (2005). Deciphering Cancer Complexities in Genetically Engineered Mice. Cold Spring Harb Symp Quant Biol 70: 283-290 [Abstract]  
  • Pati, D., Haddad, B. R., Haegele, A., Thompson, H., Kittrell, F. S., Shepard, A., Montagna, C., Zhang, N., Ge, G., Otta, S. K., McCarthy, M., Ullrich, R. L., Medina, D. (2004). Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium. Cancer Res. 64: 5608-5616 [Abstract] [Full Text]  
  • Hesselager, G., Uhrbom, L., Westermark, B., Nister, M. (2003). Complementary Effects of Platelet-derived Growth Factor Autocrine Stimulation and p53 or Ink4a-Arf Deletion in a Mouse Glioma Model. Cancer Res. 63: 4305-4309 [Abstract] [Full Text]  
  • Duensing, S., Munger, K. (2002). The Human Papillomavirus Type 16 E6 and E7 Oncoproteins Independently Induce Numerical and Structural Chromosome Instability. Cancer Res. 62: 7075-7082 [Abstract] [Full Text]  
  • Bunz, F., Fauth, C., Speicher, M. R., Dutriaux, A., Sedivy, J. M., Kinzler, K. W., Vogelstein, B., Lengauer, C. (2002). Targeted Inactivation of p53 in Human Cells Does Not Result in Aneuploidy. Cancer Res. 62: 1129-1133 [Abstract] [Full Text]  
  • Tolbert, D., Lu, X., Yin, C., Tantama, M., Van Dyke, T. (2002). p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo. Mol. Cell. Biol. 22: 370-377 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»